🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Subjects are dosed twice daily at 9AM and 9PM for 12 weeks. The primary eff...
Status
Completed
Location
Multiple Locations
Start Date
2010-04
Trial ID
NCT01111890
Treatments Being Tested
Both Cosopt® and Xalatan® plus Timoptic® will significantly lower IOP, howe...
Status
Withdrawn
Location
Meir Medical Center
Start Date
2008-12
Trial ID
NCT00815373
Treatments Being Tested
To analyze Cosopt® in terms of its effects on ocular perfusion pressure and...
Status
Completed
Location
Indiana University School of Medicine, Department of Ophthalmology
Start Date
2010-06
Trial ID
NCT01145898
Treatments Being Tested
The purpose of this study was to assess patient preference regarding ocular...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01340014
The purpose of this study is to evaluate AZORGA® Ophthalmic Suspension comp...
Status
Completed
Location
Contact Alcon Japan Ltd. for Trial Locations
Start Date
2014-12
Trial ID
NCT02325518
This study compares the efficacy and tolerability/comfort of brimonidine/ti...
Status
Completed
Location
Multiple Locations
Start Date
2005-05
Trial ID
NCT00822055
Treatments Being Tested
The purpose of this study is to assess patient preference of AZARGA® compar...
Status
Completed
Location
Centro Oftalmológico
Start Date
2010-09
Trial ID
NCT01471158
Evaluate the effectiveness of dorzolamide-timolol (Cosopt®) as first line t...
Status
Completed
Location
Multiple Locations
Start Date
2006-05-31
Trial ID
NCT00546286